Related references
Note: Only part of the references are listed.Carbenoxolone Alters the Morphology of Adipose Tissues and Downregulates Genes Involved in Adipogenesis, Glucose Transport and Lipid Metabolism in High-Fat Diet-fed Mice
S. Sano et al.
HORMONE AND METABOLIC RESEARCH (2012)
Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11β-hydroxysteroid dehydrogenase type 1 inhibitor
Andreas Blum et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
Stephane Quideau et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Upregulation of Hepatic 11 beta-Hydroxysteroid Dehydrogenase-1 Expression in Calcium-Deficient Rats
Junji Takaya et al.
ANNALS OF NUTRITION AND METABOLISM (2011)
Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344)
Ji Seon Park et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)
Haixia Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Increased Whole-Body and Sustained Liver Cortisol Regeneration by 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Men With Type 2 Diabetes Provides a Target for Enzyme Inhibition
Roland H. Stimson et al.
DIABETES (2011)
11 beta-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus
G. Hollis et al.
DIABETES OBESITY & METABOLISM (2011)
Current therapeutic strategies in non-alcoholic fatty liver disease
J. K. Dowman et al.
DIABETES OBESITY & METABOLISM (2011)
Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
P. U. Feig et al.
DIABETES OBESITY & METABOLISM (2011)
Obesity Affects the Liver - The Link between Adipocytes and Hepatocytes
Alexander Wree et al.
DIGESTION (2011)
Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
Juan Liu et al.
ENDOCRINE JOURNAL (2011)
Magnesium deficiency in pregnant rats alters methylation of specific cytosines in the hepatic hydroxysteroid dehydrogenase-2 promoter of the offspring
Junji Takaya et al.
EPIGENETICS (2011)
In Vivo Activity of 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Man: Effects of Prednisolone and Chenodesoxycholic Acid
S. Diederich et al.
HORMONE AND METABOLIC RESEARCH (2011)
The metabolic syndrome: time to get off the merry-go-round?
G. M. Reaven
JOURNAL OF INTERNAL MEDICINE (2011)
Synthesis of Potent and Orally Efficacious 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor HSD-016
Zhao-Kui Wan et al.
JOURNAL OF ORGANIC CHEMISTRY (2011)
Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension
Sukrut Shah et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
Flavonoids Health Benefits and Their Molecular Mechanism
Z. -P. Xiao et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
High Fructose Diets Increase 11β-Hydroxysteroid Dehydrogenase Type 1 in Liver and Visceral Adipose in Rats Within 24-h Exposure
Edra London et al.
OBESITY (2011)
Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES-Reykjavik Study
Lauren J. Kim et al.
OBESITY (2011)
Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: Possible contribution of 11 β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue
Noriko Tagawa et al.
STEROIDS (2011)
Small for Gestational Age and Magnesium in Cord Blood Platelets: IntrauterineMagnesium DeficiencyMay Induce Metabolic Syndrome in Later Life
Junji Takaya et al.
JOURNAL OF PREGNANCY (2011)
The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
Paolo Ferrari
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Azabicyclic sulfonamides as potent 11β-HSD1 inhibitors
Unmesh Shah et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles
Scott P. Webster et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Emodin, a natural product, selectively inhibits 11β-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice
Ying Feng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Hypothalamic-Pituitary-Adrenal (HPA) axis functioning in relation to body fat distribution
Femke Rutters et al.
CLINICAL ENDOCRINOLOGY (2010)
11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
R. Ge et al.
CURRENT MEDICINAL CHEMISTRY (2010)
The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2010)
Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis
C. Karlsson et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: Quercetin as a potential antidiabetic agent acting via 11 beta-Hydroxysteroid dehydrogenase type 1 inhibition
Mariana Torres-Piedra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
11 beta-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
Stuart A. Morgan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Weight Loss after Gastric Bypass Surgery in Women Is Followed by a Metabolically Favorable Decrease in 11β-Hydroxysteroid Dehydrogenase 1 Expression in Subcutaneous Adipose Tissue
Kotryna Simonyte et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Discovery of a Potent, Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor for Clinical Study: Identification of (S)-2-(1S,2S,4R)-Bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)
Murielle M. Veniant et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The glucocorticoid-activating enzyme 11 beta-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: Physiological and toxicological considerations
Alex Odermatt et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
11β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation
Claudia A. Staab et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Laura L. Gathercole et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
Nicholas Michael Morton
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue
Sakamuri S. S. Vara Prasad et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Fructose and metabolic diseases: New findings, new questions
Luc Tappy et al.
NUTRITION (2010)
Overexpression of 11 beta-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients
Rene Baudrand et al.
OBESITY SURGERY (2010)
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Luc Tappy et al.
PHYSIOLOGICAL REVIEWS (2010)
The influence of beverage composition on delivery of phenolic compounds from coffee and tea
Mario G. Ferruzzi
PHYSIOLOGY & BEHAVIOR (2010)
Effects of bile acids on rat hepatic microsomal type I 11β-hydroxysteroid dehydrogenase
Yorio Maeda et al.
STEROIDS (2010)
Cell-based assay for screening 11β-hydroxysteroid dehydrogenase 1 inhibitors
Young Sik Cho et al.
ANALYTICAL BIOCHEMISTRY (2009)
Discovery of novel dual functional agent as PPARγ agonist and 11β-HSD1 inhibitor for the treatment of diabetes
Yang-liang Ye et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275
Michael Siu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
4-(Phenylsulfonamidomethyl) benzamides as potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice
Xu Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Selective Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome Is the Target Liver, Fat, or Both?
Paul M. Stewart et al.
DIABETES (2009)
11β-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle
Stuart A. Morgan et al.
DIABETES (2009)
Antidiabetic effects of 11β-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis
D. J. Lloyd et al.
DIABETES OBESITY & METABOLISM (2009)
Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
D. H. van Raalte et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation
Mark S. Cooper et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Panagiotis Anagnostis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Kimber L. Stanhope et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Efficacious 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors in the Diet-Induced Obesity Mouse Model
Zhao-Kui Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity
Edra London et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Selective inhibition of 11β-hydroxysteroid dehydrogenase 1 by 18α-glycyrrhetinic acid but not 18β-glycyrrhetinic acid
Dirk Classen-Houben et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11β-hydroxysteroid dehydrogenase 1
Zoltan Balazs et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
11β-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP+ and is stimulated by extracellular glucose
Anna A. Dzyakanchuk et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Regulation of the Hypothalamic-Pituitary-Adrenal Axis
Anastasios Papadimitriou et al.
NEUROIMMUNOMODULATION (2009)
Calcium intake is inversely associated with metabolic syndrome in postmenopausal women: Korea National Health and Nutrition Survey, 2001 and 2005
Geum Joon Cho et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Obesity Is Accompanied by Disturbances in Peripheral Glucocorticoid Metabolism and Changes in FA Recycling
Kotryna Simonyte et al.
OBESITY (2009)
11β-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients
Rodrigo Munoz et al.
OBESITY SURGERY (2009)
Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls
Madhusmita Misra et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Direct protein-protein interaction of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen
Atanas G. Atanasov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Sub-chronic administration of the 11β-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity
Ashley Taylor et al.
BIOLOGICAL CHEMISTRY (2008)
Distinctive molecular inhibition mechanisms for selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
Hua Tu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Impaired glucose tolerance and insulin resistance are associated with increased adipose 11β-hydroxysterold dehydrogenase type 1 expression and elevated hepatic 5α-reductase activity
Jeremy W. Tomlinson et al.
DIABETES (2008)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
7-Oxysterols Modulate Glucocorticoid Activity in Adipocytes through Competition for 11 beta-Hydroxysteroid Dehydrogenase Type
Malgorzata Wamil et al.
ENDOCRINOLOGY (2008)
11-Beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) inhibitors in Type 2 diabetes mellitus and obesity
Katherine A. Hughes et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Association between the metabolic syndrome and serum cortisol in overweight Latino youth
Marc J. Weigensberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Modulation of 11β-hydroxysteroid dehydrogenase (11βHSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11βHSD1 inhibitor
Rachel Courtney et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
I. J. Bujalska et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Xiaosen Ouyang et al.
JOURNAL OF HEPATOLOGY (2008)
Discovery of novel, potent benzamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model
Lisa D. Julian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitors:: Enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57B1/6 mice
Lars Johansson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Development of 11β-HSD1 inhibitors for the treatment of type 2 diabetes
Clarence Hale et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Inhibition of 11βHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice
Maj Sundbom et al.
BMC Pharmacology & Toxicology (2008)
Demonstration of proof of mechanism and pharmacokinetics and pharmacodynamic relationship with 4 '-cyano-biphenyl-4-sulfonic acid (6-amino-pyridin-2-yl)-amide (PF-915275), an inhibitor of 11 beta-hydroxysteroid dehydrogenase type 1, in cynomolgus monkeys
B. Ganesh Bhat et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Structural characterization and pharmacodynamic effects of an orally active 11 beta-hydroxysteroid dehydrogenase type 1 inhibitor
Clarence Hale et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Modulation of glucocorticoid action and the treatment of type-2 diabetes
Jeremy W. Tomlinson et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Type 2 diabetes and metabolic syndrome are associated with increased expression of 11β-hydroxysteroid dehydrogenase 1 in obese subjects
L. Alberti et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors
Chester Yuan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Adipose tissue expression of 11β-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity
Daniela Espindola-Antunes et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
11β-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues
Magalie Berthiaume et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Altered activity of 11β-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes
Christina Jang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Inhibition of 11B-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Malgorzata Wamil et al.
DRUG DISCOVERY TODAY (2007)
Inhibition of human and rat 11β-hydroxysteroid dehydrogenase type 1 by 18β-glycyrrhetinic acid derivatives
Xiangdong Su et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11β-hydroxysteroid dehydrogenase type 1
Magalie Berthiaume et al.
ENDOCRINOLOGY (2007)
Inhibition of 11β-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis
Jeremy W. Tomlinson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Nutritional strategies in the prevention and treatment of metabolic syndrome
Sabrina E. Feldeisen et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2007)
Cortisol - cause and cure for metabolic syndrome?
B. R. Walker
DIABETIC MEDICINE (2006)
The metabolic syndrome: Concepts and controversy
Lewis W. Johnson et al.
MAYO CLINIC PROCEEDINGS (2006)
Coffee inhibits the reactivation of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1:: A glucocorticoid connection in the anti-diabetic action of coffee?
Atanas G. Atanasov et al.
FEBS LETTERS (2006)
Inhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice
SJY Wang et al.
DIABETOLOGIA (2006)
11β-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients
Raoul Desbriere et al.
OBESITY (2006)
Active site variability of type 1 11β-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons
M Hult et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Coffee and type 2 diabetes: From beans to beta-cells
RM van Dam
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2006)
Endogenous selective inhibitors of 11β-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin
SA Latif et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Perhydroquinolylbenzamides as novel inhibitors of 11β-hydroxysteroid dehydrogenase type 1
GM Coppola et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes
BM Abdallah et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
A Hermanowski-Vosatka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Coffee consumption and risk of type 2 diabetes - A systematic review
RM van Dam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women
M Duclos et al.
OBESITY RESEARCH (2005)
Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysterold dehydrogenase type 1
IJ Bujalska et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity
EE Kershaw et al.
DIABETES (2005)
Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome -: 11β-hydroxysteroid dehydrogenase type 1
PM Stewart
CLINICAL MEDICINE (2005)
Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone
TC Sandeep et al.
DIABETES (2005)
Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats
AJ Drake et al.
ENDOCRINOLOGY (2005)
Different responsiveness in body weight and hepatic 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1 mRNA to 11β-HSD inhibition by glycyrrhetinic acid treatment in obese and lean Zucker rats
RS Li et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice
NM Morton et al.
DIABETES (2004)
11β-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus
G Valsamakis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Novel 18β-glycyrrhetinic acid analogues as potent and selective inhibitors of 11β-hydroxysteroid dehydrogenases
XD Su et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action:: from metabolism to memory
JR Seckl et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Weight loss increases 11β-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue
JW Tomlinson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Down-regulation of adipose 11β-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice:: A potential adaptive mechanism counteracting metabolic disease
NM Morton et al.
ENDOCRINOLOGY (2004)
Effect of chenodeoxycholic acid on 11β-hydroxysteroid dehydrogenase in various target tissues
DJ Morris et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Clinical efficacy of magnesium supplementation in patients with type 2 diabetes
K Yokota et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2004)
11β-hydroxysteroid dehydrogenase type 1:: A tissue-specific regulator of glucocorticoid response
JW Tomlinson et al.
ENDOCRINE REVIEWS (2004)
Metabolic syndrome without obesity:: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice
JM Paterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD):: flavanone selectively inhibits 11β-HSD1 reductase activity
RAS Schweizer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains
P Alberts et al.
ENDOCRINOLOGY (2003)
Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
N Draper et al.
NATURE GENETICS (2003)
Is 11β-hydroxysteroid dehydrogenase type 1 a therapeutic target?: Effects of carbenoxolone in lean and obese Zucker rats
DEW Livingstone et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Effects of the 11 beta-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes
RC Andrews et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance
RC Andrews et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Coffee consumption and risk of type 2 diabetes mellitus
RM van Dam et al.
LANCET (2002)
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
P Alberts et al.
DIABETOLOGIA (2002)
Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs.: Discovery of potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1
T Barf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Tissue-specific changes in peripheral cortisol metabolism in obese women:: Increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity
E Rask et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
A switch in dehydrogenase to reductase activity of 11,6-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells
IJ Bujalska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
11 beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: From de-activation to generation of cortisol
IJ Bujalska et al.
ENDOCRINE RESEARCH (2002)
A transgenic model of visceral obesity and the metabolic syndrome
H Masuzaki et al.
SCIENCE (2001)
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice.
NM Morton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Regulation of glucocorticoid receptor α and β isoforms and type I 11β-hydroxysteroid dehydrogenase expression in human skeletal muscle cells:: A key role in the pathogenesis of insulin resistance?
CB Whorwood et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Tissue-specific dysregulation of cortisol metabolism in human obesity
E Rask et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
In the search for specific inhibitors of human 11β-hydroxysteroid-dehydrogenases (11β-HSDs):: chenodeoxycholic acid selectively inhibits 11β-HSD-I
S Diederich et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Share Paper
